On a Roll: FDA OKs Genentech's Gazyva for Untreated Follicular Lymphoma Post author:Sam Post published:November 16, 2017 Post category:BioPharma Genentech scored two approvals from the FDA this week. Source: BioSpace You Might Also Like On a Roll, Seattle Genetics Plans to Hire 200 in 2017 January 23, 2017 Boehringer CFO Quits After 16 Months on the Job Over Differences in Strategy December 14, 2017 As the IDO Battle Gets Ugly, Bristol-Myers Shows Off Early Data for Combo Trial November 9, 2017
